Fiala

Peptide library › Cancer & imaging

Degarelix

Also known as Firmagon

FDA-approved drugCancer & imaging

Monthly hormone-blocking injection for advanced prostate cancer that lowers testosterone fast, without an initial flare.

What people use it for

What Degarelix does in the body

A GnRH antagonist: it blocks the brain's hormone signal directly, so testosterone falls within days. Unlike GnRH agonists, there's no temporary rise first.

Strength of evidence

Strong: Phase 3 trials showed testosterone suppression at least as good as leuprolide.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved in 2008. Prescription only.

How it's taken

Route: Injection under the skin of the abdomen: a starting dose, then every 28 days

How long it lasts (half-life): About 7 weeks for the monthly depot

Storage

Stored and prepared by the pharmacy or clinic, following the product label.

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Degarelix privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Degarelix in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Cancer & imaging